Wee Sung Wook, Lee Jeong Kyu
From the Department of Ophthalmology, College of Medicine, Chung-Ang University Hospital, Seoul, Republic of Korea.
J Craniofac Surg. 2014 May;25(3):898-901. doi: 10.1097/SCS.0000000000000559.
The aim of this study was to investigate the clinical outcomes of conjunctiva-Müller muscle resection (CMMR) in patients with mild to moderate ptosis, the factors related to successful procedures, and the influence of CMMR on dry eye symptoms and signs.
In a tertiary university hospital, the medical records of 30 patients who had CMMR were retrospectively reviewed, including the detailed preoperative and postoperative eyelid measurements, surgical outcomes, and dry eye evaluations. Inclusion criteria included older than 18 years, acquired ptosis, and no previous eyelid surgery or trauma.
The surgery had a success rate of 86.7%. In the patients who responded to phenylephrine application with a marginal reflex distance 1 (MRD1) increase of more than 2 mm, the postoperative MRD1 correction was 2.41 ± 0.84 mm, whereas the postoperative MRD1 correction was 1.19 ± 0.78 mm in the group with responses of less than 2 mm. The postoperative MRD1 correction was 1.21 ± 0.80 mm in the group with a negative response. Seven patients complained of dry eye symptoms and showed a transiently significant aggravation in the Schirmer test and ocular surface disease index score after the procedure, which normalized within 2 months postoperatively.
Responsiveness to phenylephrine is directly correlated with the postoperative results. Nevertheless, even in the patients with negative phenylephrine response, some degree of eyelid elevation can be expected. Damage to goblet cells after the procedure may result in defective tear production, leading to transient aggravation of dry eye symptoms.
本研究旨在探讨结膜-米勒肌切除术(CMMR)治疗轻至中度上睑下垂患者的临床疗效、与手术成功相关的因素以及CMMR对干眼症状和体征的影响。
在一所三级大学医院,对30例行CMMR手术患者的病历进行回顾性分析,包括术前和术后详细的眼睑测量、手术效果及干眼评估。纳入标准包括年龄大于18岁、后天性上睑下垂、既往无眼睑手术或外伤史。
手术成功率为86.7%。对苯肾上腺素应用有反应且边缘反射距离1(MRD1)增加超过2mm的患者,术后MRD1矫正值为2.41±0.84mm,而反应小于2mm组的术后MRD1矫正值为1.19±0.78mm。无反应组的术后MRD1矫正值为1.21±0.80mm。7例患者主诉干眼症状,术后泪液分泌试验和眼表疾病指数评分出现短暂显著加重,术后2个月内恢复正常。
对苯肾上腺素的反应与术后结果直接相关。然而,即使是对苯肾上腺素无反应的患者,也可预期有一定程度的眼睑提升。术后杯状细胞损伤可能导致泪液分泌不足,从而导致干眼症状短暂加重。